Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study.
Dekker EN, van Dam JL, Janssen QP, Besselink MG, DeSilva A, Doppenberg D, van Eijck CHJ, Nasar N, O'Reilly EM, Paniccia A, Prakash LR, Tzeng CD, Verkolf EMM, Wei AC, Zureikat AH, Katz MHG, Groot Koerkamp B; Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. Dekker EN, et al. Among authors: desilva a. J Clin Oncol. 2024 Apr 20;42(12):1357-1367. doi: 10.1200/JCO.23.01311. Epub 2024 Feb 5. J Clin Oncol. 2024. PMID: 38315954
Encouraging long-term survival following autophagy inhibition using neoadjuvant hydroxychloroquine and gemcitabine for high-risk patients with resectable pancreatic carcinoma.
AlMasri SS, Zenati MS, Desilva A, Nassour I, Boone BA, Singhi AD, Bartlett DL, Liotta LA, Espina V, Loughran P, Lotze MT, Paniccia A, Zeh HJ 3rd, Zureikat AH, Bahary N. AlMasri SS, et al. Among authors: desilva a. Cancer Med. 2021 Oct;10(20):7233-7241. doi: 10.1002/cam4.4211. Epub 2021 Sep 24. Cancer Med. 2021. PMID: 34559451 Free PMC article. Review.
No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer.
Liu H, D'Alesio M, AlMasri S, Hammad A, Desilva A, Lebowitz S, Rieser C, Ashwat E, Hampton E, Khachfe H, Laffey M, Singhi A, Bahary N, Lee K, Zureikat A, Paniccia A. Liu H, et al. Among authors: desilva a. HPB (Oxford). 2023 May;25(5):521-532. doi: 10.1016/j.hpb.2023.01.016. Epub 2023 Feb 3. HPB (Oxford). 2023. PMID: 36804826 Free article.
Alternative models to support weight loss in chronic musculoskeletal conditions: effectiveness of a physiotherapist-delivered intensive diet programme for knee osteoarthritis, the POWER randomised controlled trial.
Allison K, Jones S, Hinman RS, Pardo J, Li P, DeSilva A, Quicke JG, Sumithran P, Prendergast J, George E, Holden MA, Foster NE, Bennell KL. Allison K, et al. Among authors: desilva a. Br J Sports Med. 2024 May 2;58(10):538-547. doi: 10.1136/bjsports-2023-107793. Br J Sports Med. 2024. PMID: 38637135 Clinical Trial.
Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection.
Panda S, Morgan J, Cheng C, Saito M, Gilman RH, Ciobanu N, Crudu V, Catanzaro DG, Catanzaro A, Rodwell T, Perera JSB, Chathuranga T, Gunasena B, DeSilva AD, Peters B, Sette A, Lindestam Arlehamn CS. Panda S, et al. Among authors: desilva ad. Nat Commun. 2024 Jan 26;15(1):765. doi: 10.1038/s41467-024-45058-9. Nat Commun. 2024. PMID: 38278794 Free PMC article.
71 results